Non-alcoholic fatty liver disease (NAFLD) is a prevalent medical problem worldwide and frequently coexists with obesity and its associated conditions. This session will review the difference between non-alcoholic fatty liver and non-alcoholic steatohepatitis, as well as the differential diagnosis of fatty liver. Guidance on the clinical assessment of NAFLD, utilizing laboratory values, imaging studies and other preclinical tests will be reviewed, as well as the role of liver biopsy. A review of the therapeutic armamentarium with focus on the liver specific effects. Additionally, this session will review the role and effect of lifestyle and pharmacological treatment as well as more invasive interventions such as bariatric surgery and other procedures.

CME/CE Expiration Date: 4/25/24

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.